Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
Article content HALIFAX, Nova Scotia — Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced the…